You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Restasis

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Disease Trial (HU007, Restasis, Moisview Eye drop)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Feb 22, 2023

Dry Eye Trial in Brecksville (Cyclosporin, Loteprednol Etabonate, Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert)

Completed
  • Dry Eye
  • Brecksville, Ohio
    Cleveland Eye Clinic
May 9, 2022

Dry Eye Syndromes Trial (Oph1, Restasis)

Not yet recruiting
  • Dry Eye Syndromes
  • (no location specified)
Jan 7, 2022

Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)

Recruiting
  • Dry Eye Syndromes
  • SCAI-001 0.01% eyedrop
  • +2 more
  • Bucheon, Korea, Republic of
  • +10 more
Feb 21, 2023

Ocular Surface Disease Trial in Needham (Restasis)

Recruiting
  • Ocular Surface Disease
  • Restasis
  • Needham, Massachusetts
    BostonSight
Mar 6, 2022

Management of Punctal Stenosis Trial in Al Farwaniyah (0.05% cyclosporin (Restasis®, Allergan Inc), mini-monoka stent)

Completed
  • Management of Punctal Stenosis
  • 0.05% cyclosporin (Restasis®, Allergan Inc)
  • mini-monoka stent
  • Al Farwānīyah, Farwanyia, Kuwait
    Farwanyia Hospital
Mar 15, 2023

Dry Eye Trial in United States (Voclosporin Ophthalmic Solution, Restasis®)

Completed
Has Results
  • Dry Eye
  • Garden Grove, California
  • +6 more
Jul 5, 2021

Ocular Surface Disease Trial in Needham (cyclosporine ophthalmic emulsion 0.05%)

Withdrawn
  • Ocular Surface Disease
  • cyclosporine ophthalmic emulsion 0.05%
  • Needham, Massachusetts
    BostonSight
Jul 20, 2021

Dry Eye, Meibomian Gland Dysfunction Trial in United States (TearCare System, Restasis)

Active, not recruiting
  • Dry Eye
  • Meibomian Gland Dysfunction
  • TearCare System
  • Restasis
  • Scottsdale, Arizona
  • +13 more
Sep 12, 2022

Epiphora Trial in Kuwait (topical 0.05% CsA (Restasis®, Allergan Inc, Irvine, California)twice daily dose,)

Completed
  • Epiphora
  • topical 0.05% CsA (Restasis®, Allergan Inc, Irvine, California)twice daily dose,
  • Kuwait, Farwanyia, Kuwait
    Farwanyia Hospital
Nov 19, 2020

Dry Eye Syndromes Trial in Seongnam (HU007, Restasis eye drop)

Completed
  • Dry Eye Syndromes
  • Seongnam, Korea, Republic of
    Seoul National University Bundang Hospital
May 11, 2020

Dry Eye Syndrome Trial in Seoul (HU007, Restasis, Moisview)

Completed
  • Dry Eye Syndrome
  • Seoul, Korea, Republic of
    Seoul ST.Mary's Hospital
May 6, 2020

Primary Sjogren Syndrome, Secondary Sjogren Syndrome, Aqueous Deficient Dry Eye Disease Trial in Sao Paulo (Restasis, Refresh

Completed
  • Primary Sjogren Syndrome
  • +3 more
  • Restasis
  • Refresh Endura
  • Sao Paulo, SP, Brazil
    Departamento de Oftalmologia da Escola Paulista de Medicina - UN
Sep 20, 2020

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Dry Eye Trial in Houston (Cyclosporin 0.05% emulsion, Endura, Refresh artificial tears)

Terminated
Has Results
  • Dry Eye
  • Cyclosporin 0.05% emulsion
  • Endura, Refresh artificial tears
  • Houston, Texas
    Alkek Eye Center, Dept of Ophthalmology, Baylor College of Medic
Feb 12, 2020

Keratoconjunctivitis Sicca Trial in Irvine (Lotemax, Restasis, Soothe® Lubricant Eye Drops)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Irvine, California
    Bausch & Lomb Incorporated
Aug 28, 2019

Patterns, Real-world Effectiveness, and Healthcare Resource

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
May 10, 2023

Dry Eye Syndromes Trial in Andover (cyclosporine 0.05% ophthalmic emulsion, carboxymethylcellulose-based lubricant eye drops)

Completed
Has Results
  • Dry Eye Syndromes
  • cyclosporine 0.05% ophthalmic emulsion
  • carboxymethylcellulose-based lubricant eye drops
  • Andover, Massachusetts
    (unnamed)
Apr 9, 2019

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

Completed
Has Results
  • Dry Eye Disease
  • Cyclosporine Ophthalmic Emulsion 0.05%
  • Pittsburgh, Pennsylvania
    (unnamed)
Apr 10, 2019

Dry Eye Syndrome Trial in Charleston (Cyclosporin A Restasis®, Blink tears, Systane)

Completed
Has Results
  • Dry Eye Syndrome
  • Cyclosporin A Restasis®
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina, Storm Eye Institute
Oct 9, 2018

Dry Eye, Sjogren Syndrome Trial in Cairo (Cyclosporins, Tacrolimus)

Completed
  • Dry Eye
  • Sjogren Syndrome
  • Cairo, Egypt
    Pavly Moawad
May 20, 2019

Safety of Tacrolimus Drops in Vernal Keratoconjunctivitis

Completed
  • Vernal Keratoconjunctivitis
  • QUICK questionnaire and 6 additional questions
  • Retrospective collection of clinical data from the patients' medical records
  • Paris, France
    Hôpital Fondation A. de Rothschuld
Nov 16, 2021

Dry Eye Syndromes Trial in United States (Cyclosporine A, Placebo)

Completed
Has Results
  • Dry Eye Syndromes
  • Cyclosporine A
  • Placebo
  • Newport Beach, California
  • +3 more
Oct 23, 2019

Dry Eye Syndrome Trial (COE 2*1 (Restasis) + PFAT Refresh Single dose) 8*1, AS 50% eye drops 8*1)

Completed
  • Dry Eye Syndrome
  • COE 2*1 (Restasis) + PFAT Refresh Single dose) 8*1
  • AS 50% eye drops 8*1
  • (no location specified)
Sep 9, 2018

Dry Eye Syndromes Trial in United States (Vehicle, Sham, Cyclosporine New Ophthalmic Formulation)

Terminated
Has Results
  • Dry Eye Syndromes
  • Artesia, California
  • +7 more
Apr 12, 2018